These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32558420)

  • 1. Management of pediatric cardiac transplantation candidates with pulmonary hypertension and high pulmonary vascular resistance.
    Yakut K; Varan B; Erdoğan İ; Cindik N; Gökdemir M; Gümüş A; Tokel NK; Sezgin A
    Turk J Pediatr; 2020; 62(3):461-467. PubMed ID: 32558420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
    J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
    Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
    Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
    Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
    Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M
    Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Cuppoletti A; Rossel V; Vallejos I; Roig E
    Clin Transplant; 2006; 20(2):239-44. PubMed ID: 16640533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications.
    Lim HS; Zaphiriou A
    J Card Fail; 2016 Feb; 22(2):117-24. PubMed ID: 26547011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of pulmonary hypertension reversibility test with sodium nitroprusside in stratification of early death risk after orthotopic heart transplantation.
    Zakliczynski M; Zebik T; Maruszewski M; Swierad M; Zembala M
    Transplant Proc; 2005 Mar; 37(2):1346-8. PubMed ID: 15848716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension in adults with systemic right ventricles referred for cardiac transplantation.
    Kim YY; Awh K; Acker M; Atluri P; Bermudez C; Crespo M; Diamond JM; Drajpuch D; Forde-Mclean R; Fuller S; Goldberg L; Mazurek J; Mascio C; Menachem JN; Rame E; Ruckdeschel E; Tobin L; Wald J
    Clin Transplant; 2019 Apr; 33(4):e13496. PubMed ID: 30770573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation.
    Bundgaard H; Boesgaard S; Mortensen SA; Arendrup H; Aldershvile J
    Scand Cardiovasc J; 1997; 31(6):339-42. PubMed ID: 9455782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated pulmonary vascular resistance and cardiac transplantation.
    Addonizio LJ; Gersony WM; Robbins RC; Drusin RE; Smith CR; Reison DS; Reemtsma K; Rose EA
    Circulation; 1987 Nov; 76(5 Pt 2):V52-5. PubMed ID: 3311456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical circulatory support is effective to treat pulmonary hypertension in heart transplant candidates disqualified due to unacceptable pulmonary vascular resistance.
    Zakliczyński M; Pacholewicz J; Copik I; Maruszewski M; Hrapkowicz T; Przybylski R; Zembala M
    Kardiochir Torakochirurgia Pol; 2018 Mar; 15(1):23-26. PubMed ID: 29681957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide in the preoperative evaluation of pulmonary hypertension in heart transplant candidates.
    Mahajan A; Shabanie A; Varshney SM; Marijic J; Sopher MJ
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):51-6. PubMed ID: 17289480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.
    Torres Macho J; Delgado Jimenez JF; Sanz Salvo J; Gonzalez Mansilla A; Sanchez Sanchez V; Gamez Diez S; Escribano Subias P; Saenz de la Calzada C
    Transplant Proc; 2009; 41(6):2477-9. PubMed ID: 19715956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.